Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents

Prostate cancer is a leading cause of cancer-related death in men worldwide. Luteinizing hormone-releasing hormone receptor (LHRH-R) agonists and antagonists are known to achieve castration-level testosterone suppression; however, long-term data comparing the survival benefits of these therapies are...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen, Hao Zeng
Formato:	Artigo
Idioma:	Inglês
Publicado:	China Anti-Cancer Association 2024-11-01
Series:	Cancer Biology & Medicine
Assuntos:	luteinizing hormone-releasing hormone receptor agonists luteinizing hormone-releasing hormone receptor antagonists prostate cancer long-term survival next-generation hormonal agents
Acceso en liña:	https://www.cancerbiomed.org/content/21/11/1012
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!